Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,030,832
  • Shares Outstanding, K 397,760
  • Annual Sales, $ 18,471 M
  • Annual Income, $ 12,202 M
  • 60-Month Beta 1.70
  • Price/Sales 2.97
  • Price/Cash Flow 4.47
  • Price/Book 3.21
Trade MRNA with:

Options Overview Details

View History
  • Implied Volatility 77.19% ( +1.83%)
  • Historical Volatility 69.71%
  • IV Percentile 76%
  • IV Rank 55.31%
  • IV High 97.60% on 02/23/22
  • IV Low 51.93% on 06/08/21
  • Put/Call Vol Ratio 1.16
  • Today's Volume 20,088
  • Volume Avg (30-Day) 21,684
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 563,296
  • Open Int (30-Day) 532,547

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 4.72
  • Number of Estimates 9
  • High Estimate 5.88
  • Low Estimate 2.02
  • Prior Year 6.46
  • Growth Rate Est. (year over year) -26.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
119.01 +14.49%
on 05/12/22
155.46 -12.36%
on 05/04/22
-13.87 (-9.24%)
since 04/20/22
3-Month
119.01 +14.49%
on 05/12/22
188.00 -27.53%
on 03/22/22
-9.49 (-6.51%)
since 02/18/22
52-Week
119.01 +14.49%
on 05/12/22
497.49 -72.61%
on 08/10/21
-29.72 (-17.91%)
since 05/20/21

Most Recent Stories

More News
Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding

Different dynamics are at work for these vaccine stocks.

PFE : 52.47 (+3.59%)
MRNA : 136.25 (-4.97%)
NVAX : 53.42 (-8.57%)
Here's How Moderna Could Top $450 Again

Three elements may lift the stock.

MRNA : 136.25 (-4.97%)
Moderna to Present at the UBS 2022 Global Healthcare Conference

CAMBRIDGE, MA / ACCESSWIRE / May 18, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in a fireside...

MRNA : 136.25 (-4.97%)
Why Pfizer Looks Better Than Moderna as a Long-Term Buy

In a post-COVID world, there are fewer question marks about Pfizer than there are about Moderna.

MRNA : 136.25 (-4.97%)
PFE : 52.47 (+3.59%)
BHVN : 142.03 (+0.69%)
2 Top Healthcare Stocks to Buy for the Long Haul

These two stocks are posting strong results despite the broader market sell-off.

MRNA : 136.25 (-4.97%)
RGEN : 154.53 (-0.06%)
Moderna (MRNA) Stock Rises 4%: What's Behind the Upside?

Moderna (MRNA) stock rises more than 4% on May 17. The COVID-19 vaccine-maker attracts investors on the back of a promising update from one of its competitors.

JNJ : 176.98 (+1.75%)
PFE : 52.47 (+3.59%)
MRNA : 136.25 (-4.97%)
BNTX : 163.00 (-2.90%)
Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children

Pfizer (PFE) and partner BioNTech gets authorization for emergency use of booster dose of its COVID-19 vaccine, Comirnaty, in children aged between 5 years and 11 years.

PFE : 52.47 (+3.59%)
MRK : 93.55 (+1.59%)
MRNA : 136.25 (-4.97%)
BNTX : 163.00 (-2.90%)
Vertex (VRTX) Outperforms Industry This Year So Far: Here's Why

Vertex's (VRTX) cystic franchise sales continue to grow. Vertex has a broad clinical non-CF pipeline, which is progressing rapidly.

VRTX : 258.59 (+1.23%)
MRNA : 136.25 (-4.97%)
ABBV : 151.01 (-0.47%)
CRSP : 56.34 (-0.27%)
Moderna Just Made a $700,000 Mistake

But it's not the stock that investors should be worried about.

MRNA : 136.25 (-4.97%)
XRAY : 37.75 (+1.15%)
IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY and CAMBRIDGE, MA / ACCESSWIRE...

MRNA : 136.25 (-4.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 156.98
2nd Resistance Point 150.88
1st Resistance Point 143.56
Last Price 136.25
1st Support Level 130.14
2nd Support Level 124.04
3rd Support Level 116.72

See More

52-Week High 497.49
Fibonacci 61.8% 352.91
Fibonacci 50% 308.25
Fibonacci 38.2% 263.59
Last Price 136.25
52-Week Low 119.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar